Intellia Therapeutics, Inc.

The role involves building the commercial FP&A infrastructure, including sophisticated revenue models and gross-to-net frameworks for a pre-revenue biotech. The Director will partner with Commercial and Access teams to manage launch strategy spend and provide revenue projections to the C-suite.

The Patient Access Liaison serves as a field-based expert supporting providers and patients in navigating reimbursement, coding, and billing for lonvo-z. They are responsible for assessing site readiness and collaborating with internal teams to ensure a seamless experience from prescription to treatment.

The Director of Medical Communications leads the development and execution of global medical communication and publication plans to address data gaps. This includes managing publications working groups, creating medical education initiatives, and overseeing vendors to ensure scientific integrity and regulatory compliance.

Lead the global GCP quality framework and R&D QA activities to ensure compliance across clinical development portfolios. Drive inspection readiness, manage internal and external audit programs, and foster a proactive quality culture within the organization.

The Senior Director provides strategic leadership in establishing and executing pharmacology and toxicology strategies across multiple therapeutic platforms. They are responsible for overseeing cross-functional teams to ensure regulatory success and defining long-term nonclinical development frameworks.

The Regional Scientific Director serves in a customer-facing medical role, establishing trusted partnerships within the healthcare community to facilitate scientific exchange, medical education, and insight identification with Key Opinion Leaders (KOLs) and healthcare providers regarding Intellia’s gene editing programs (nex-z and lonvo-z). Responsibilities include developing scientific engagement plans, gathering external insights, supporting Phase 3 clinical trials, and ensuring compliance in all interactions.